Company: NGVT
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001653477-25-000108
Chunk: 123

Company: Ingevity Corp
Filing Date: 2025-08-05
Form: 10-Q
Item: Part I, Item 8
Chunk 123
---
 projects, impacting our road technologies product line, and weakness in industrial demand within our industrial specialties product line. Segment EBITDA improved $22.7 million compared to the prior year quarter, reflecting the positive impact of repositioning actions, including benefits from cost savings actions and lower raw material costs, primarily CTO. 

Three Months Ended June 30,Six Months Ended June 30,In millions2025202420252024Total Performance Chemicals - Net sales$167.9 $185.5 $262.9 $332.5 Road Technologies product line119.5 129.1 163.8 174.8 Industrial Specialties product line48.4 56.4 99.1 157.7 Segment EBITDA$32.0 $9.3 $31.7 $(1.3)

Net Sales Comparison of Three and Six Months Ended June 30, 2025 and June 30, 2024:Change vs. prior yearIn millionsPrior year Net salesVolumePrice/MixCurrency effectCurrent year Net salesThree months ended June 30, 2025 vs. 2024$185.5 (26.4)8.2 0.6 $167.9 Road Technologies product line129.1 (12.2)2.5 0.1 119.5 Industrial Specialties product line56.4 (14.2)5.7 0.5 48.4 Six months ended June 30, 2025 vs. 2024$332.5 (78.6)8.4 0.6 $262.9 Road Technologies product line174.8 (14.5)3.4 0.1 163.8 Industrial Specialties product line157.7 (64.1)5.0 0.5 99.1 

Three Months Ended June 30, 2025 vs. 2024

Segment net sales. The decrease of $17.6 million in 2025 was driven by a volume decline of $26.4 million (14 percent), as a result of a decrease in industrial specialties ($14.2 million) and road technologies ($12.2 million). This was partially offset by favorable pricing and sales mix of $8.2 million (four percent), attributable to an increase in industrial specialties ($5.7 million) and road technologies